The Russian Direct Investment Fund (RDIF) has submitted applications to the World Health Organization (WHO) for Emergency Use Listing and prequalification of the country’s very first registered COVID-19 vaccine Sputnik V.
The Russian Federation is one of the first countries to apply to WHO for prequalification of its vaccine against the novel coronavirus infection.
The Prequalification of Medicines Programme is a United Nations programme managed by WHO. It is the only global medicines quality assurance programme. The WHO prequalification of medicines assesses the quality, safety and efficacy of medicines. A medicinal product is included in the list of prequalified products subject to compliance with established requirements and standards of WHO.
The accelerated vaccine registration under the EUL procedure will make the Russian vaccine available globally in a shorter time frame than usual procedures and supporting the global efforts to prevent the coronavirus infection.
A successful prequalification will enable Sputnik V to be included in the list of medicines used by international procurement agencies and countries to guide bulk purchasing of medicines.